1 The DANBIO registry and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark Objectives ...
Department of Laboratory Diagnostics, Changzheng Hospital, Second Military Medical University, Shanghai, China Correspondence to Dr Yang Zaixing and Professor Renqian Zhong, Department of Laboratory ...
1 Division of Arthritis and Rheumatic Diseases – OP09, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201, USA 2 Department of Pathology, Oregon Health and Science ...
1 Arthritis Research UK Centre for Genetics and Genomics, Manchester Academic Health Science Centre 2 Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester ...
1 Department of Rheumatology, University College London Hospitals, Arthur Stanley House, 40-50 Tottenham Street, London W1T 4NJ, UK 2 Institute of Nuclear Medicine, University College London Hospitals ...
1 Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA 2 Sjögren's Syndrome Clinic, Molecular ...
Objective: To determine in a prospective population-based cohort study relationships between different measures of body mass and the incidence of severe knee and hip osteoarthritis defined as ...
23 Istituto Giannina Gaslini, Pediatria II, Reumatologia and Universià degli Studi di Genova, Genova, Italy 24 Istituto Giannina Gaslini, Pediatria II, Reumatologia, Genova, Italy Correspondence to ...
T11: Diagnostics and imaging procedures - what’s new in imaging - miscellaneous topics T13: Furthering clinical management S1: Adaptive immunity in rheumatic diseases Adaptive immunity (T cells and B ...
Objectives The aim of this study was to assess the accuracy and readability of the answers generated by large language model (LLM)-chatbots to common patient questions about low back pain (LBP).
Objective To assess the efficacy/safety of ivarmacitinib, a selective Janus kinase (JAK) 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis (RA) who had an inadequate ...
The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of ...